You can buy or sell Ekso Bionics and other stocks, options, ETFs, and crypto commission-free!
Ekso Bionics Holdings, Inc. engages in the design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following business segments: EksoHealth, EksoWorks, and Other. Read More The EksoHealth segment consists of the design, engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in Richmond, CA.
52 Week High
52 Week Low
Research And Development
Seeking AlphaFeb 28
Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q4 2018 Results - Earnings Call Transcript
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2018 Results Earnings Conference Call February 28, 2019 4:30 PM ET Company Participants Matt Steinberg - Investor Relations Contact, Lazar Partners Jack Peurach - President and Chief Executive Officer Jack Glenn - Chief Financial Officer Conference Call Participants Bruce Nudell - SunTrust Robinson Humphrey Operator Greetings and welcome to the Ekso Bionics' Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-o...
Stock Price, News, & Analysis for Ekso Bionics
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, an...
Expected May 6, After Hours